Valuation: PharmaEssentia Corporation

Market Cap 580B 18.22B 15.61B 14.6B 13.37B 25.09B 1,743B 25.42B 173B 67.29B 876B 68.42B 66.93B 2,897B P/E 2026 *
52.9x
P/E 2027 * 34.5x
Enterprise Value 554B 17.39B 14.89B 13.94B 12.76B 23.94B 1,664B 24.26B 165B 64.21B 836B 65.29B 63.87B 2,764B EV / Sales 2026 *
19.6x
EV / Sales 2027 * 14.1x
Free-Float
77.98%
Yield 2026 *
0.29%
Yield 2027 * 0.17%
1 day+1.82%
1 week-6.67%
Current month+32.08%
1 month+19.15%
3 months+94.61%
6 months+114.21%
Current year+230.42%
1 week 1,345
Extreme 1345
1,545
1 month 1,015
Extreme 1015
1,550
Current year 423.7
Extreme 423.699083
1,550
1 year 398.05
Extreme 398.050392
1,550
3 years 228.27
Extreme 228.269713
1,550
5 years 56.05
Extreme 56.051993
1,550
10 years 43.54
Extreme 43.541837
1,550
Manager TitleAgeSince
Chief Executive Officer - 31/12/2016
Director of Finance/CFO - 13/10/2015
President - 24/06/2015
Director TitleAgeSince
Director/Board Member 73 30/04/2024
Director/Board Member - 04/08/2021
Director/Board Member - 26/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%-6.67%+247.46%+393.10% 18.22B
-3.00%+2.27%+77.60%+109.33% 72.12B
+1.90%+23.53%+56.60%+97.76% 65.85B
+5.12%+25.22%+5.24%-0.82% 29.28B
+0.55%+1.64%-5.15%+471.68% 27.47B
+2.74%+12.98%+62.84%+28.14% 26.7B
+0.47%+6.12%+36.66%-13.79% 20.06B
+0.94%+3.36%+18.55%+532.94% 16.4B
+0.73%+5.54%+39.71%+153.07% 13.4B
-0.41%+0.54%+319.81%+203.73% 12.3B
Average +1.09%+7.59%+85.93%+197.52% 30.18B
Weighted average by Cap. +0.69%+9.12%+69.68%+159.68%

Financials

2026 *2027 *
Net sales 28.28B 888M 761M 712M 652M 1.22B 84.97B 1.24B 8.41B 3.28B 42.68B 3.33B 3.26B 141B 38.61B 1.21B 1.04B 972M 890M 1.67B 116B 1.69B 11.48B 4.48B 58.27B 4.55B 4.45B 193B
Net income 11.05B 347M 297M 278M 255M 478M 33.21B 484M 3.29B 1.28B 16.68B 1.3B 1.27B 55.18B 17.03B 535M 458M 429M 392M 737M 51.18B 746M 5.07B 1.98B 25.71B 2.01B 1.96B 85.04B
Net Debt -26.52B -833M -714M -668M -611M -1.15B -79.7B -1.16B -7.89B -3.08B -40.04B -3.13B -3.06B -132B -34.73B -1.09B -934M -874M -800M -1.5B -104B -1.52B -10.33B -4.03B -52.42B -4.1B -4.01B -173B
Logo PharmaEssentia Corporation
PharmaEssentia Corp is a Taiwan-based company mainly engaged in the research, development, production and sale of new drugs. The Company is engaged in the research and development of new drugs, which are used for treatment of hematology, such as meloproliferative neoplasms (MPN), neutropenia, anemia; infectious disease, such as hepatitis C and hepatitis B; dermatology, such as psoriasis, and neurology, such as multiple sclerosis, among others. The Company’s products include KX01, P1101, Polycythemia Vera (PV), PEG-GCSF, PEG-EPO and others. The Company distributes its products within domestic market and to overseas markets.
Employees
131
Date Price Change Volume
21/08/26 NT$1,400.00 +1.82% 1,610,602
20/08/26 NT$1,375.00 -1.79% 2,530,233
19/08/26 NT$1,400.00 0.00% 2,584,371
18/08/26 NT$1,400.00 -0.71% 5,232,294
17/08/26 NT$1,410.00 -6.00% 4,986,375
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,400.00TWD
Average target price
1,312.17TWD
Spread / Average Target
-6.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock